DC Circ. Adds Feather To DEA's Regulatory Authority Hat
On June 30, 2017, the D.C. Circuit upheld the U.S. Drug Enforcement Administration's authority to take prescription drug suppliers to task for failing to proactively investigate, stop and report drug diversion...To view the full article, register now.
Already a subscriber? Click here to view full article